Shaperon Inc. (KOSDAQ:378800)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Biotechnology	17.70M	215.25M	2.00B
Biotechnology Growth	-91.77%	-89.24%	-
Total	17.70M	215.25M	2.00B
Total Growth	-91.77%	-89.24%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
South Korea	17.70M	215.25M	2.00B
South Korea Growth	-91.77%	-89.24%	-
Total	17.70M	215.25M	2.00B
Total Growth	-91.77%	-89.24%	-

Source: S&P Global Market Intelligence.